{
  "claim_id": "claim_002",
  "claim": "Cell- and egg-based flu vaccines have the potential to develop mutations during production, which may reduce their effectiveness.",
  "document": {
    "pdf_name": "Zimmerman_et_al.__2023_",
    "source_pdf": "data/clinical_files/Zimmerman et al. (2023).pdf",
    "total_pages": 7,
    "total_blocks": 106,
    "total_characters": 22573
  },
  "extraction_result": {
    "success": true,
    "total_snippets_found": 1,
    "error": null
  },
  "extracted_evidence": [
    {
      "id": 1,
      "quote": "because it is not subject to mutations to the A (H3 N2) glycosylation binding site that reduce the effectiveness of egg based vaccines.",
      "relevance_explanation": "This quote explicitly states that egg-based vaccines can develop mutations at the A (H3 N2) glycosylation binding site, which can reduce their effectiveness. This directly supports the claim that mutations during production may impact vaccine efficacy."
    }
  ],
  "model_used": "gpt-4.1"
}